NeuroBo Pharmaceuticals I... (NRBO)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14
Revenue	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	28.00K	72.00K	67.00K	17.00K	-	-	-	-	-
Gross Profit	-	-28.00K	-72.00K	-67.00K	-17.00K	-	-	-	-	-
Operating Income	-15.89M	-19.63M	-15.30M	-29.72M	-20.18M	-22.80M	-33.12M	-14.70M	-8.08M	-266.00K
Interest Income	461.00K	2.19K	14.00K	39.00K	-	-	-	-	-	-
Pretax Income	-12.47M	-13.97M	-15.28M	-29.68M	-21.31M	-23.64M	-33.41M	-14.59M	-9.03M	-320.00K
Net Income	-12.47M	-6.12M	-15.22M	-29.59M	-22.43M	-23.64M	-33.41M	-14.59M	-9.03M	-320.00K
Selling & General & Admin	6.73M	8.64M	8.75M	7.85M	2.70M	8.49M	10.44M	5.96M	3.18M	214.00K
Research & Development	9.16M	2.78M	6.55M	21.87M	17.48M	14.31M	22.69M	8.74M	3.99M	52.00K
Other Expenses	-	-83.00K	-	-1K	12.15M	-178.00K	10.44M	-	-	-
Operating Expenses	15.89M	11.42M	15.30M	29.72M	20.18M	22.80M	33.12M	14.70M	7.17M	266.00K
Interest Expense	-	2.19M	-	39.00K	22.00K	654.00K	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	10.38M	-	-	-
Cost & Expenses	15.89M	11.42M	15.30M	29.72M	20.18M	22.80M	33.12M	14.70M	7.17M	266.00K
Income Tax	-	-7.85M	-62.00K	-85.00K	1.12M	654.00K	286.00K	-136.82K	-146.00K	55.00K
Shares Outstanding (Basic)	5.07M	321.70K	96.43K	67.57K	21.77K	141.71K	13.80K	7.75K	7.07K	7.07K
Shares Outstanding (Diluted)	5.07M	321.70K	96.43K	67.57K	21.77K	141.71K	13.80K	7.75K	7.07K	7.07K
EPS (Basic)	-2.46	-19.01	-157.85	-437.95	-1.03K	-166.8	-2.42K	-1.88K	-1.28K	-45.27
EPS (Diluted)	-2.46	-19.01	-157.85	-437.95	-1.03K	-166.8	-2.42K	-1.88K	-1.28K	-45.27
EBITDA	-15.88M	-11.40M	-15.21M	-29.61M	-21.17M	-15.49M	-33.09M	-14.50M	-6.07M	-283.00K
Depreciation & Amortization	7.00K	28.00K	72.00K	67.00K	17.00K	6.67M	60.00K	-17.00K	2.01M	-1K